The global inhalable drugs market is expected to grow at a CAGR of around 6.4% from 2019 to 2026 and projected to reach the market value of around US$ 41.5Bn by 2026.
Inhalable drugs refer to the group of substances that people inhale into the lungs to treat infections or particular diseases. These drugs are inhaled as a dry powder or as a solution by aerosols. Dry powders are inhaled into the lungs by taking a deep, fast breath through the inhaler. Moreover, the common aerosol used drugs are bronchodilators and anti-inflammatory agents, which are used for respiratory diseases including asthma and chronic obstructive pulmonary disease (COPD). In addition, aerosol drug delivery for respiratory diseases has advantages including minimal systemic side effects among others.
Market Dynamics
The inhalable drugs are also gaining growth owing to the increasing popularity of the procedure due to its advantages over the oral and parenteral drug administration like direct injection into the body or by bypassing the skin and mucous membranes. The rising prevalence of non-respiratory diseases such as Parkinson’s disease and diabetes is accelerating market growth. Along with these, the growing geriatric population and advancements in inhalable drug therapies are further supporting the market value. Additionally, increasing investment in research and development activities coupled with unmet medical needs is expected to create potential opportunities over the forecast period.
On the flip side, stringent regulations and availability of alternative therapy are likely to hinder the growth over the forecast period.
By type, Dry Powder Formulation segment accounted for the maximum share
In 2018, the dry powder formulation segment dominated the inhalable drugs market with major shares due to the high efficacy and better results. The formulation of high dose drugs coupled with the innovative developments in the field is particularly supporting the segment growth.
Respiratory diseases segment accounted for the major share in the Inhalable Drugs Market
The application of inhalable drugs in respiratory diseases segment held the potential share in the year 2018. The respiratory diseases where inhalable drugs are used include asthma, chronic obstructive pulmonary disease (COPD), infectious diseases, and other respiratory diseases. The rising prevalence of respiratory diseases owing to the changing lifestyle, and increasing air pollution is contributing to the segment growth.
The market research study on “Inhalable Drugs Market– Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026”, offers a detailed insight into the global Inhalable Drugs market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights into the global inhalable drugs market, its product type, application, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global inhalable drugs market size and volume, and segment markets by product type, application, and geography along with the information on companies operating in the market. The inhalable drugs market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America and Middle East and Africa. For each region, the market size and volume for different segments have been covered under the scope of the report.
North America held the major market share of Inhalable Drugs Market
In terms of region, North America dominated the global inhalable drugs market in the year 2018 and the region is also anticipated to maintain its dominance over the estimated year. The availability of advanced products and increasing awareness programs by the government and major players in the regional market is further supporting the market growth.
The Asia Pacific is expected to witness the fastest growth over the forecast period owing to the increasing disposable income and increasing investment in the healthcare sector by government and non-governmental bodies.
The players profiled in the report include AstraZeneca, Sanofi, Vectura, Mylan, GlaxoSmithKline, Mundipharma, Boehringer Ingelheim International GmbH, Cipla Inc. and Others. The major players involved in mergers and acquisitions and new product development for the expansion of market share.
Market Segmentation
Market By Type
- Suspension Aerosol
- Solution Aerosol
- Dry Powder Formulation
Market By Application
- Respiratory diseases
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Infectious Diseases
- Other respiratory diseases
- Non-respiratory diseases
Market By Geography
- North America
- Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Table Of Content:
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Inhalable Drugs
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Inhalable Drugs Market By Type
1.2.2.1. Global Inhalable Drugs Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.2.2. Global Inhalable Drugs Market Revenue Share By Type in 2018
1.2.2.3. Suspension Aerosol
1.2.2.4. Solution Aerosol
1.2.2.5. Dry Powder Formulation
1.2.3. Inhalable Drugs Market By Application
1.2.3.1. Global Inhalable Drugs Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Global Inhalable Drugs Market Revenue Share By Application in 2018
1.2.3.3. Respiratory diseases
1.2.3.3.1. Asthma
1.2.3.3.2. Chronic Obstructive Pulmonary Disease (COPD)
1.2.3.3.3. Infectious Diseases
1.2.3.3.4. Other respiratory diseases
1.2.3.4. Non-respiratory diseases
1.2.4. Inhalable Drugs Market By Geography
1.2.4.1. Global Inhalable Drugs Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Inhalable Drugs Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Inhalable Drugs Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Inhalable Drugs Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Inhalable Drugs Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Inhalable Drugs Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Inhalable Drugs Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Inhalable Drugs Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Inhalable Drugs Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Inhalable Drugs Major Manufacturers in 2018
CHAPTER 4. INHALABLE DRUGS MARKET BY TYPE
4.1. Global Inhalable Drugs Revenue By Type
4.2. Suspension Aerosol
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Solution Aerosol
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Dry Powder Formulation
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. INHALABLE DRUGS MARKET BY APPLICATION
5.1. Global Inhalable Drugs Revenue By Application
5.2. Respiratory diseases
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.2.3. Asthma
5.2.4. Chronic Obstructive Pulmonary Disease (COPD)
5.2.5. Infectious Diseases
5.2.6. Other respiratory diseases
5.3. Non-respiratory diseases
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6. NORTH AMERICA INHALABLE DRUGS MARKET BY COUNTRY
6.1. North America Inhalable Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Inhalable Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Inhalable Drugs Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 7. EUROPE INHALABLE DRUGS MARKET BY COUNTRY
7.1. Europe Inhalable Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Inhalable Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 8. ASIA-PACIFIC INHALABLE DRUGS MARKET BY COUNTRY
8.1. Asia-Pacific Inhalable Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Inhalable Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 9. LATIN AMERICA INHALABLE DRUGS MARKET BY COUNTRY
9.1. Latin America Inhalable Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Inhalable Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. Mexico
9.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 10. MIDDLE EAST & AFRICA INHALABLE DRUGS MARKET BY COUNTRY
10.1. Middle East & Africa Inhalable Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East & Africa Inhalable Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. GCC
10.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. South Africa
10.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Middle East & Africa
10.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 11. COMPANY PROFILE
11.1. AstraZeneca
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Sanofi
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Vectura
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Mylan
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. GlaxoSmithKline
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Mundipharma
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Boehringer Ingelheim International GmbH
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Cipla Inc.
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. Others
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope
